AI Needs YOUR Help Tracking Down Lancet Father 11, Richard Demirjian

Letter from father to Brian Deer and Dan Olmsted, 2011 – BMJ Deceived Lancet Parent Into Attacking Dr. Andrew Wakefield, Citation 5

His name is Richard Demirjian. His alma mater is UC Berkeley, and he is an engineer. His wife’s name is Aida, and they apparently donated a large sum of money to found an autism charity in the early nineties. Autism Investigated has reached out to the charity, but there’s no obvious way to get through to him directly.

So Autism Investigated is reaching out to you the reader. We need help tracking down Mr. Demirjian and confronting him with the fact that he’s been misled by the British Medical Journal (BMJ). If you have any information about his whereabouts and/or contact information, feel free to post in the comments below.

It is not enough to out Mr. Demirjian, we need him to publicly take back what he is quoted as claiming in the BMJ. That has partially happened, but not fully happened. So we want BMJ’s sole parent witness to denounce the journal and take back what he said about Dr. Andrew Wakefield. Demirjian owes it to the entire autism community and to himself.

He and his wife did apparently commit $60,000 to found the California non-profit, Behavioral Intervention for AutismAutism Investigated has reached out to this group to hopefully get through to Mr. Demirjian. Any further help though would be greatly appreciated.

Share on FacebookTweet about this on TwitterShare on LinkedInShare on Google+Share on RedditPin on PinterestFlattr the authorDigg thisBuffer this pageShare on TumblrShare on StumbleUpon

4 Thoughts on “AI Needs YOUR Help Tracking Down Lancet Father 11, Richard Demirjian

  1. EMF Guy on November 5, 2017 at 2:32 pm said:


    Richard Demirjian has no responsibility here
    “confront him” you should not

    Cajole him, yes
    Convince him (as he doesn’t seem to
    believe vaccines are the main problem)

    Reword your post. Don’t have people
    rely in comments say “reply in confidence” as I endeavor
    to locate and communicate…

    You think your saying “out Mr. Demirjian”
    will make HIM anxious to be keyman in a new Media Shitstorm???
    No chance.

    You think demanding…
    “We need him to publicly take back what he is quoted as claiming”
    entails any built-in leverage, suasion or inevitability
    to either compel him to speak or unravel the ratsnest?

    Richard Demirjian has done nothing wrong here…
    just being pissed off at Wakefield.. which I believe
    you have been from time to time.

    If he reads it you will never get his help
    You assume the Media is waiting to pounce
    and that is enough to make him crack…
    Not at all.

    We know it’s the thin edge of a very
    large bullshitty wedge. “They” don’t
    and they don’t care.

    And worse, even with full cooperation and disclosure
    by him .. it won’t likely generate any media shitstorm
    but will be utterly ignored. It’s only one puzzle piece
    in rewinding this demented history.

    Very unconsidered and ham-handed Jake.

    You can do much better.

  2. Hans Litten on November 6, 2017 at 2:31 pm said:

    The U.S. Food and Drug Administration approved GlaxoSmithKline’s Shingrix shingles vaccine for use in adults aged 50 and over, a move widely expected after an advisory panel to the agency last month voted unanimously to recommend its approval, the company announced on Friday.
    Shingrix is seen as an improvement over Zostavax, the only currently marketed shingles prevention vaccine, sold by Merck & Co.

    The vaccine is considered one of the more important products in Glaxo’s pipeline, with annual sales forecast to reach $1 billion by 2023, according to Thomson Reuters data.

    Glaxo said the U.S. Centers for Disease Control and Prevention’s advisory committee on immunization practices is expected to vote on a recommendation for the use of Shingrix at its meeting on Wednesday.

    The company said it expects Shingrix “will be available shortly.”The vaccine demonstrated its efficacy in two pivotal Phase III studies involving more than 29,000 subjects.

    Shingrix has shown greater protection against shingles among older recipients than Zostavax. Four years after injection, the Glaxo vaccine remained about 90 percent effective in people over age 70, while the efficacy of Zostavax declines noticeably over time.

    Older adults are most at risk for an outbreak of shingles, a painful, often debilitating blistering rash that results from reactivation of the varicella-zoster virus, which causes chickenpox and remains latent in those who have had that disease.

    Given in two doses two months apart, Shingrix also reduces incidence of nerve pain following a shingles outbreak.
    Shingrix contains a component “qs21” used to help boost efficacy from Agenus Inc, which is entitled to royalties on future sales.
    The vaccine won its first approval in Canada last week and is awaiting approval decisions in Europe, Japan and Australia.

  3. Hans Litten on November 6, 2017 at 3:14 pm said:

    Another Australian doctor breaks ranks and speak out !

    Dr. Kevin Coleman believes in vaccine choice. He’s been a noted critic of Australia’s strict no jab no pay legislation that prevents government welfares from assisting parents who refuse specific vaccinations for their children.

    Where are the rest of you ? damn cowards !

Leave a Reply

Your email address will not be published. Required fields are marked *

Post Navigation